Pharma Industry News

First patient enrolled in Oxford BioDynamics’ ALS biomarker study

ALS – amyotrophic lateral sclerosis – is a specific disease that causes the death of neurons controlling voluntary muscles.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]